Highlights CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Market Closed - OTC Markets Other stock markets 12:29:06 14/05/2024 am IST			5-day change	1st Jan Change
0.009535 ^USD	-6.70%		-6.86%	-33.10%

16/04	CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
12/01	CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14/23/14	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14/23/14	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13/23/13	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30/22/30	CI
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08/22/08	CI
CNBX Pharmaceuticals Inc. Announces That the Company Has Filed A New Patent Application Titled " Compositions Comprising Cannabinoids and Methods of Use Thereof in the Treatment of Cancer" Under the Patent Cooperation Treaty	18/22/18	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	14/22/14	CI
CNBX Pharmaceuticals Inc. Receives Grant of Patent Notice by the Patent Registry, Intellectual Property Department, the Government of the Hong Kong Special Administrative Region	05/22/05	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	12/22/12	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	13/22/13	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	30/21/30	CI
CANNABICS PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	20/21/20	AQ
Cannabics Pharmaceuticals Inc. Files 2 Provisional Patents on Compositions and Methods for Treating Cancer	18/21/18	CI
Cannabics Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	15/21/15	CI
Cannabics Pharmaceuticals Releases Interim Results of Second In-Vivo POC Study	28/21/28	CI
Cannabics Pharmaceuticals Inc. to Launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases	17/21/17	CI
Cannabics Pharmaceuticals Inc. Launches a Breast Cancer Treatment Research Program	03/21/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CNBX Pharmaceuticals Inc.

Equities

CNBX

US13764M2098

Highlights

Filters